share_log

Alaunos Therapeutics | PRER14A: Preliminary revised proxy soliciting materials

SEC ·  Oct 28, 2020 04:14
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.